C679X loss-of-function PCSK9 variant lowers fasting glucose levels in a black South African population: A longitudinal study

Our results indicated that carriers of A443T and C679X variants exhibit sustained low LDL-C levels over 5 years and have varied effects on T2D biomarkers compared to non-carriers.